These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8033364

  • 1. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T, Haavisto AM, Permi J, de Kretser D, Huhtaniemi I.
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [Abstract] [Full Text] [Related]

  • 2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
    Huhtaniemi IT, Dahl KD, Rannikko S, Hsueh AJ.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [Abstract] [Full Text] [Related]

  • 12. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM, Juul A, Petersen JH, Müller J, Groome NP, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [Abstract] [Full Text] [Related]

  • 13. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 14. Sexual dimorphism in circulating monomeric and dimeric inhibins in normal boys and girls from birth to puberty.
    Bergadá I, Rojas G, Ropelato G, Ayuso S, Bergadá C, Campo S.
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):455-60. PubMed ID: 10583312
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.